Vascular Perfusion Solutions (VPS) is a development and early-stage medical device company founded with the mission to innovate in the preservation and resuscitation of vascularized organs. VPS aims to enhance organ transplantation outcomes through its advanced oxygenated perfusion preservation solutions. Their flagship product, VP.S ENCORE®, is designed to preserve tissues and organs, thereby extending their viability for transplantation. The company primarily focuses on serving Organ Procurement Organizations (OPOs) and healthcare specialists involved in organ transplants.

Notable figures associated with VPS include a team of experienced medical professionals and researchers dedicated to advancing organ preservation technology. The company has garnered attention and support from various investors interested in medical innovations. VPS's key achievements include the development and successful implementation of VP.S ENCORE®, which has shown promising results in extending the life of preserved organs. The overall impact of VPS lies in its potential to significantly improve transplant success rates and save countless lives by addressing critical challenges in organ preservation.